Fund HoldingsKynam Capital Management, LP

Total Portfolio Value
$1.81B
Total Bought
$384.83M
Total Sold
$217.98M
Net Transaction
+$166.84M
Filing Period:
Securities
SharesValue ($K)
Q1 2026
Q2 2026
Change
Q1 2026
Q2 2026
Weight (%)
Change
VIRIDIAN THERAPEUTICS INC(VRDN)2,341,6526,453,877+4,112,22545,803118,5586.55%+72,755
TRAVERE THERAPEUTICS INC(TVTX)1,569,0182,000,000+430,98246,616113,6206.28%+67,004
LEGEND BIOTECH CORP(LEGN)1,576,2953,001,205+1,424,91028,51586,6754.79%+58,160
UROGEN PHARMA LTD(URGN)2,247,3932,434,207+186,81440,40889,5794.95%+49,171
RELAY THERAPEUTICS INC(RLAY)1,424,2593,300,000+1,875,74114,17161,7433.41%+47,572
MBX BIOSCIENCES INC(MBX)934,799934,799027,90451,6012.85%+23,697
SUMMIT THERAPEUTICS INC(SMMT)01,200,000+1,200,000017,4840.97%+17,484
IMMUNOCORE HLDGS PLC(IMCR)884,9371,375,000+490,06326,68143,6562.41%+16,975
CELLDEX THERAPEUTICS INC NEW(CLDX)5,840,5675,322,908-517,659185,263198,06510.95%+12,803
CULLINAN THERAPEUTICS INC(CGEM)3,114,1323,114,132044,25256,7083.13%+12,457
CYTOMX THERAPEUTICS INC.(CTMX)15,013,09321,703,093+6,690,00070,56281,3874.50%+10,825
INSMED INC(INSM)0100,000+100,000010,6620.59%+10,662
NURIX THERAPEUTICS INC(NRIX)1,194,7571,194,757018,51928,9851.60%+10,466
BEAM THERAPEUTICS INC(BEAM)3,682,1852,840,792-841,39387,74697,4965.39%+9,750
PRELUDE THERAPEUTICS INC(PRLD)1,592,5512,415,087+822,5365,44712,8720.71%+7,426
SUTRO BIOPHARMA INC(STRO)872,558872,558021,73528,9691.60%+7,234
PARABILIS MEDICINES INC0250,000+250,00006,8430.38%+6,843
PHARVARIS N V
COM
640,395661,795+21,40018,09122,8851.26%+4,794
ALECTOR INC2,000,0003,808,494+1,808,4944,3007,6550.42%+3,355
AMARIN CORP PLC472,382532,982+60,6006,8318,4960.47%+1,665
ENGENE THERAPEUTICS INC(ENGN)0457,855+457,85507920.04%+792
PROQR THRAPEUTICS N V
SHS EURO
1,566,3171,566,31702,5372,9130.16%+376
TRAWS PHARMA INC(TRAW)084,400+84,4000710.00%+71
VAXCYTE INC(PCVX)2,922,3352,922,3350169,817169,8759.39%+58
CANDEL THERAPEUTICS INC(CADL)200,00096,741-103,2599809960.06%+16
CARIBOU BIOSCIENCES INC(CRBU)2,503,3022,503,30204,7564,4060.24%-350
GERON CORP(GERN)6,836,3186,836,318010,1868,7500.48%-1,436
BIOHAVEN LTD(BHVN)702,8840-702,8845,9460-5,946
CLIMB BIO INC(CLYM)1,003,3410-1,003,3416,8730-6,873
WAVE LIFE SCIENCES LTD(WVE)965,1930-965,1936,9980-6,998
DESIGN THERAPEUTICS INC(DSGN)784,6060-784,6068,3480-8,348
ENGENE HOLDINGS INC
COM
1,356,8430-1,356,8439,2400-9,240
BURNING ROCK BIOTECH LTD(BNR)1,227,5551,238,563+11,00819,79110,5180.58%-9,273
SYNDAX PHARMACEUTICALS INC(SNDX)8,050,9598,050,9590188,070175,9949.73%-12,076
VERA THERAPEUTICS INC(VERA)3,398,2242,890,059-508,165136,711124,0126.85%-12,698
COGENT BIOSCIENCES INC(COGT)4,037,3313,667,097-370,234155,397141,9177.84%-13,480
EVOMMUNE INC(EVMN)625,4960-625,49614,3800-14,380
SOLENO THERAPEUTICS INC560,0000-560,00018,7490-18,749
BIOCRYST PHARMACEUTICALS INC(BCRX)5,680,7952,522,660-3,158,13554,08125,2271.39%-28,855
APELLIS PHARMACEUTICALS INC
COM
825,0000-825,00033,1900-33,190
KALVISTA PHARMACEUTICALS INC1,820,9540-1,820,95436,6560-36,656
Page 1 of 1
Kynam Capital Management, LP — 13F Holdings — Q2 2026 | TickerTrail